Lysophosphatidylcholine Acyltransferase 2 (LPCAT2) Antibody

Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Lysophosphatidylcholine Acyltransferase 2 (LPCAT2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx338475
tested applications
ELISA, WB, IHC

Description

LPCAT2 Antibody is a Rabbit Polyclonal against LPCAT2.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Lysophosphatidylcholine Acyltransferase 2 (LPCAT2)
Host
Rabbit
Reactivity
Human
Recommended Dilution
WB: 1/500 - 1/5000, IHC: 1/20 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA, WB, IHC
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q7L5N7
Gene ID
54947
Background
Antibody anti-LPCAT2
Status
RUO

Descripción

Related Products

EH2170

Human LPCAT2 (Lysophosphatidylcholine acyltransferase 2) ELISA Kit

Ver Producto
FNab04827

LPCAT2 antibody

Possesses both acyltransferase and acetyltransferase activities. Activity is calcium-dependent. Involved in platelet-activating factor(PAF) biosynthesis by catalyzing the conversion of the PAF precursor, 1-O-alkyl-sn-glycero-3-phosphocholine(lyso-PAF) into 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine(PAF). Also converts lyso-PAF to 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine(PC), a major component of cell membranes and a PAF precursor. Under resting conditions, acyltransferase activity is preferred. Upon acute inflammatory stimulus, acetyltransferase activity is enhanced and PAF synthesis increases. Also catalyzes the conversion of 1-acyl-sn-glycero-3-phosphocholine to 1,2-diacyl-sn-glycero-3-phosphocholine.

Ver Producto
P2156

Recombinant Human LPCAT2

Ver Producto